SCHEMBL3725544

SCHEMBL3725544

COc1cccc(-c2ccc(N)c(Cl)c2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.57
ALDH1A1 P00352 2/20 0.57
TSHR P16473 1/20 0.57
MAPK1 P28482 1/20 0.57
MAOB P27338 2/20 0.51
HDAC2 Q92769 1/20 0.50
MAP4K4 O95819 1/20 0.49
ESR2 Q92731 1/20 0.49
CYP1A1 P04798 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2E1 P05181 1/20 0.48
CYP2C8 P10632 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2A6 P11509 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP4B1 P13584 1/20 0.48
CYP2B6 P20813 1/20 0.48
CYP3A5 P20815 1/20 0.48
CYP2A7 P20853 1/20 0.48
CYP3A7 P24462 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4083971 0.86 MAOB (0.51) CYP3A4ALDH1A1MAOBHDAC2MAP4K4
SCHEMBL1335447 0.84 CYP3A4 (0.55) CYP3A4ALDH1A1MAOBMAP4K4CYP1A1
SCHEMBL29655214 0.84 MAOB (0.56) CYP3A4ALDH1A1TSHRMAOBHDAC2
SCHEMBL3732621 0.82 MAP4K4 (0.53) CYP3A4ALDH1A1TSHRMAPK1MAP4K4
SCHEMBL990337 0.81 CYP3A4 (0.71) CYP3A4ALDH1A1TSHRMAOBHDAC2
SCHEMBL30482672 0.81 CYP3A4 (0.71) CYP3A4ALDH1A1TSHRMAOBHDAC2
SCHEMBL1337887 0.79 MAOB (0.55) CYP3A4ALDH1A1MAOBHDAC2MAP4K4
SCHEMBL922966 0.79 ALDH1A1 (0.57) CYP3A4ALDH1A1TSHRMAPK1CYP1A2
SCHEMBL1180343 0.79 ABL1 (0.69) CYP3A4ALDH1A1MAOBCYP1A1CYP1A2
SCHEMBL196765 0.79 CYP3A4 (0.73) CYP3A4ALDH1A1MAOBCYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8691852-B2 Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors AMIRALL, S.A. (ES) 2014-04-08 US disclosed
US-20120294854-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS LABORATORIOS ALMIRALL, S.A. 2012-11-22 US disclosed
US-8258308-B2 Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors LABORATORIOS ALMIRALL, S.A. (ES) 2012-09-04 US disclosed
EP-2121614-B1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS ALMIRALL SA (ES) 2012-06-20 EP disclosed
US-20100074898-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS LABORATORIOS ALMIRALL, S.A. (ES) 2010-03-25 US disclosed
EP-2121614-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS Almirall, S.A. (ES) 2009-11-25 EP disclosed
WO-2008077639-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS LABORATORIOS ALMIRALL, S.A. (ES) 2008-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100074898-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS DHODH, NQO2, DAO CYP3A4 2249/4885ALDH1A1 147/4885TSHR 3745/4885
US-20120294854-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS DHODH, NQO2, DAO CYP3A4 2249/4885ALDH1A1 147/4885TSHR 3745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.